Trobix Bio

Trobix BioTrobix Bio
Trobix Bio

Trobix Bio

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

DR 5Speed 942019Active13San Diego, United States
Rate

About

Trobix Bio is developing orally administered precision oncology therapeutics by leveraging its TBX™ technology platform. This platform utilizes CRISPR, phage, and synthetic biology to precisely re-program specific bacterial activities within the human microbiome.
Frequently asked

What does Trobix Bio do?

Trobix Bio is developing orally administered precision oncology therapeutics by leveraging its TBX™ technology platform. This platform utilizes CRISPR, phage, and synthetic biology to precisely re-program specific bacterial activities within the human microbiome.

What is Trobix Bio's revenue?

StartupHub estimates Trobix Bio's annual revenue at $2.2M (range $1.2M to $3.5M, 64% confidence), based on comparable companies in the sector.

What is Trobix Bio's valuation?

StartupHub estimates Trobix Bio's effective valuation at $11.9M (range $7.5M to $18.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Trobix Bio raised?

Trobix Bio has raised a total of $3M in funding. The most recent round on record is Series A.

Where is Trobix Bio headquartered?

Trobix Bio is headquartered in San Diego, United States.

When was Trobix Bio founded?

Trobix Bio was founded in 2019.

What industry does Trobix Bio operate in?

Trobix Bio operates in Life Sciences, Microbiome, Oncology, Therapeutics, Biotech, MedTech.

How many employees does Trobix Bio have?

Trobix Bio has approximately 13 people on record.

HEADCOUNT
13
DOMAIN RATING
5
Comments

No comments yet. Be the first to share your take.